{"id":"https://openalex.org/W2139205106","doi":"https://doi.org/10.18632/oncoscience.135","title":"MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments","display_name":"MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments","alternate_titles":[],"publication_year":2015,"publication_date":"2015-02-20","ids":{"openalex":"https://openalex.org/W2139205106","doi":"https://doi.org/10.18632/oncoscience.135","mag":"2139205106","pmid":"https://pubmed.ncbi.nlm.nih.gov/25859552","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4381702"},"language":"en","primary_location":{"id":"doi:10.18632/oncoscience.135","doi":"https://doi.org/10.18632/oncoscience.135","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncoscience.135","pdf_url":"https://doi.org/10.18632/oncoscience.135","source":{"id":"https://openalex.org/S4210206977","display_name":"Oncoscience","issn_l":"2331-4737","issn":["2331-4737"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncoscience","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2139205106"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.18632/oncoscience.135","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109848836","display_name":"Mariska Sauzine Miranda","orcid":"https://orcid.org/0009-0003-4435-9082","observed_orcids":["https://orcid.org/0009-0003-4435-9082"]},"institutions":[{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Mariska Miranda","raw_affiliation_strings":["QIMR Berghofer Medical Research Institute, Herston, Qld, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"QIMR Berghofer Medical Research Institute, Herston, Qld, Australia","institution_ids":["https://openalex.org/I217937681"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058374354","display_name":"Esdy N. Rozali","orcid":"https://orcid.org/0000-0003-1032-8467","observed_orcids":["https://orcid.org/0000-0003-1032-8467"]},"institutions":[{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Esdy Rozali","raw_affiliation_strings":["QIMR Berghofer Medical Research Institute, Herston, Qld, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"QIMR Berghofer Medical Research Institute, Herston, Qld, Australia","institution_ids":["https://openalex.org/I217937681"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042627450","display_name":"Kum Kum Khanna","orcid":"https://orcid.org/0000-0001-8650-5381","observed_orcids":["https://orcid.org/0000-0001-8650-5381"]},"institutions":[{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Kum Kum Khanna","raw_affiliation_strings":["QIMR Berghofer Medical Research Institute, Herston, Qld, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"QIMR Berghofer Medical Research Institute, Herston, Qld, Australia","institution_ids":["https://openalex.org/I217937681"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036264210","display_name":"Fares Al\u2010Ejeh","orcid":"https://orcid.org/0000-0002-1553-0077","observed_orcids":["https://orcid.org/0000-0002-1553-0077"]},"institutions":[{"id":"https://openalex.org/I217937681","display_name":"QIMR Berghofer Medical Research Institute","ror":"https://ror.org/004y8wk30","country_code":"AU","type":"facility","lineage":["https://openalex.org/I217937681"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Fares Al-Ejeh","raw_affiliation_strings":["QIMR Berghofer Medical Research Institute, Herston, Qld, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"QIMR Berghofer Medical Research Institute, Herston, Qld, Australia","institution_ids":["https://openalex.org/I217937681"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I217937681"],"apc_list":null,"apc_paid":null,"fwci":1.0588,"has_fulltext":true,"cited_by_count":42,"citation_normalized_percentile":{"value":0.73132108,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"2","issue":"2","first_page":"99","last_page":"101"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.7836999893188477,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.7836999893188477,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.21150000393390656,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erk5","display_name":"ERK5","score":0.9760000109672546},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.8240000009536743},{"id":"https://openalex.org/keywords/map-kinase-cascade","display_name":"MAP kinase cascade","score":0.906000018119812},{"id":"https://openalex.org/keywords/chemotherapy-response","display_name":"chemotherapy response","score":0.656000018119812},{"id":"https://openalex.org/keywords/patient-survival","display_name":"patient survival","score":0.652999997138977},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.621999979019165},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7459999918937683}],"concepts":[{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.77083420753479},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.5556082725524902},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5536547303199768},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5215449333190918},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5115474462509155},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4990360736846924},{"id":"https://openalex.org/C132149769","wikidata":"https://www.wikidata.org/wiki/Q899651","display_name":"Mitogen-activated protein kinase","level":3,"score":0.4707777202129364},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.4621911644935608},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44388431310653687},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42901724576950073},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3928084969520569},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.19447532296180725},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.1258990466594696}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.18632/oncoscience.135","doi":"https://doi.org/10.18632/oncoscience.135","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncoscience.135","pdf_url":"https://doi.org/10.18632/oncoscience.135","source":{"id":"https://openalex.org/S4210206977","display_name":"Oncoscience","issn_l":"2331-4737","issn":["2331-4737"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncoscience","raw_type":"journal-article"},{"id":"pmid:25859552","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25859552","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncoscience","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4381702","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4381702/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncoscience","raw_type":"Text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.794.9811","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.794.9811","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/1f/44/oncoscience-02-0099.PMC4381702.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.18632/oncoscience.135","doi":"https://doi.org/10.18632/oncoscience.135","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncoscience.135","pdf_url":"https://doi.org/10.18632/oncoscience.135","source":{"id":"https://openalex.org/S4210206977","display_name":"Oncoscience","issn_l":"2331-4737","issn":["2331-4737"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncoscience","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5559578836","display_name":"EGFR-directed radioimmunotherapy combined with chemotherapy and DNA repair inhibition: development towards clinical application for aggressive cancers","funder_award_id":"FT130101417","funder_id":"https://openalex.org/F4320334704","funder_display_name":"Australian Research Council"},{"id":"https://openalex.org/G890732987","display_name":"From transcriptome metanalysis to targeted therapies in triple negative breast cancer","funder_award_id":"1082458","funder_id":"https://openalex.org/F4320334705","funder_display_name":"National Health and Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320306239","display_name":"Conquer Cancer Foundation","ror":"https://ror.org/027327e78"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"},{"id":"https://openalex.org/F4320334704","display_name":"Australian Research Council","ror":"https://ror.org/05mmh0f86"},{"id":"https://openalex.org/F4320334705","display_name":"National Health and Medical Research Council","ror":"https://ror.org/011kf5r70"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2139205106.pdf","grobid_xml":"https://content.openalex.org/works/W2139205106.grobid-xml"},"referenced_works_count":9,"referenced_works":["https://openalex.org/W1572182491","https://openalex.org/W1932917546","https://openalex.org/W1969317010","https://openalex.org/W2025795146","https://openalex.org/W2085934079","https://openalex.org/W2094794384","https://openalex.org/W2158099593","https://openalex.org/W6656628680","https://openalex.org/W6683326501"],"related_works":["https://openalex.org/W1932917546","https://openalex.org/W2970104912","https://openalex.org/W2810154626","https://openalex.org/W2626392284","https://openalex.org/W2594665350","https://openalex.org/W2992201391","https://openalex.org/W3083587334","https://openalex.org/W3152783474","https://openalex.org/W2496228699","https://openalex.org/W2013162510"],"abstract_inverted_index":{"The":[0],"MEK5-ERK5":[1,80],"pathway":[2],"is":[3,12,41],"a":[4],"mammalian":[5],"mitogen-activated":[6],"protein":[7],"(MAP)":[8],"kinase":[9,20],"cascade":[10],"that":[11,39],"not":[13],"well":[14],"studied":[15],"compared":[16],"to":[17],"other":[18],"MAP":[19],"cascades.":[21],"Two":[22],"independent":[23],"studies":[24,60],"by":[25],"Al-Ejeh":[26],"et":[27,31],"al.":[28,32],"and":[29,61],"Ortiz-Ruiz":[30],"published":[33],"in":[34,45,70],"Oncotarget":[35],"last":[36],"year":[37],"concluded":[38],"ERK5":[40,69],"an":[42],"attractive":[43],"target":[44],"triple":[46,75],"negative":[47,76],"breast":[48,77],"cancer.":[49],"In":[50],"this":[51],"perspective,":[52],"we":[53],"briefly":[54],"describe":[55],"the":[56,63],"findings":[57],"of":[58,65,68,86],"these":[59],"propose":[62],"use":[64],"pharmacological":[66],"inhibition":[67],"combination":[71],"with":[72,83,89],"chemotherapy":[73],"against":[74],"cancer":[78],"because":[79],"overexpression":[81],"associates":[82],"poor":[84],"survival":[85],"patients":[87],"treated":[88],"chemotherapy.":[90]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2139205106","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
